Bemegride

DB13740ExperimentalSmall molecule

Bemegride is a CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.

Mechanism: Pharmacologically active on GABA(A) Receptor
Curator reviewed
Formula / weight: C₈H₁₃NO₂ · 155.197 g/mol (avg)
Code names: NP13

Resolves to

Compound

UNII57DQA39DO2CAS64-65-3ChEMBLCHEMBL1214192ChEBI92269

Clinical / RWD

ATCR07AB05

Structure

InChIKeyORRZGUBHBVWWOP-UHFFFAOYSA-NSMILESCCC1(C)CC(=O)NC(=O)C1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1ATC codeIncluding every combination product, plus 6 drug categories

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Bemegride, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account